ライフサイエンスコーパス: associated virus

1 ugh to be packaged efficiently into an adeno-associated virus.

2 ingle systemic delivery of recombinant adeno-associated virus.

3 mice and mice injected with 3xMyc-FXR1 adeno-associated virus.

4 ine heart was performed by means of an adeno-associated virus.

5 onor template delivered by recombinant adeno-associated virus.

6 -229E may constitute a descendant of camelid-associated viruses.

7 ty of gene therapy through infusion of adeno-associated virus 1 (AAV1)/SERCA2a in patients with heart

8 mice were intracranially injected with adeno-associated virus 1 expressing murine IL-6 (AAV1-mIL-6).

9 Adeno-associated virus 2 (AAV2) and adenovirus 5 (Ad5) are pro

10 tudied mostly in the dependoparvovirus adeno-associated virus 2 (AAV2) and the protoparvovirus minute

11 Adeno-associated virus 2 (AAV2) depends on the simultaneous pr

12 r either virus to replicate.IMPORTANCE Adeno-associated virus 2 (AAV2) differs from most other viruse

13 On the other hand, adeno-associated virus 2 (AAV2) is a helper-dependent dependop

14 rAAV2/HBoV1, in which the recombinant adeno-associated virus 2 (rAAV2) genome is pseudopackaged by t

15 Both adeno-associated virus 2 and adenovirus 5 are currently though

16 Suppression of Sema3e using adeno-associated virus 2 carrying short hairpin RNA targeting

17 acy of gene therapy with a recombinant adeno-associated virus 2/2 (rAAV2/2) vector carrying the RPE65

18 determine the effects of Grapevine Leafroll associated Virus 3 (GLRaV-3) on fruit composition and ch

19 AMT-060 combines an adeno-associated virus-5 (AAV5) vector with a liver-specific p

20 s performed in mice given infusions of adeno-associated virus 6-NF-kappaB-luciferase, to assess activ

21 ive imaging of mice given infusions of adeno-associated virus 6-NF-kappaB-luciferase.

22 , were given injections of recombinant adeno-associated virus 8 vector that expressed the primary miR

23 proof-of-concept experiments, we used Adeno-Associated Virus 9 (AAV9) to deliver single-guide RNA (s

24 Similarly, adeno-associated virus 9 (AAV9)-mediated restoration of Erk5 e

25 L by generating two self-complementary adeno-associated virus 9 (scAAV9) constructs to address CLN3 d

26 approach using two self-complementary adeno-associated virus 9 (scAAV9) constructs to address CLN3 d

27 In the present study, we delivered adeno-associated virus 9 carrying green fluorescent protein-CI

28 erolaemia liver chimeric mice using an adeno-associated virus 9-based gene therapy and restore normal

29 levels in a mouse model of I/R, as did adeno-associated virus 9-mediated ATF6 overexpression.

30 Adeno-associated virus 9-mediated Cdk5 inhibitory peptide reve

31 stnatal muscle tissue in vivo, we used adeno-associated virus-9 (AAV9) to deliver gene-editing compon

32 Adeno-associated virus (AAV) -delivered gene therapy has under

33 We applied STN-DBS in an adeno-associated virus (AAV) 1/2-driven human mutated A53T alp

34 nuclease mRNA via electroporation and adeno-associated virus (AAV) 6 delivery of donor constructs in

35 ssessed the therapeutic efficacy of an adeno-associated virus (AAV) 9-mbetagal vector infused systemi

36 in 1-month old mdx:utr (-/-) mice via adeno-associated virus (AAV) 9-mediated RNA interference.

37 The Rep68 protein from adeno-associated virus (AAV) combines a DNA binding and endonu

38 ications that use the highly versatile adeno-associated virus (AAV) delivery vehicle.

39 tokines in a murine model of CHB using adeno-associated virus (AAV) delivery.

40 delivery with naturally recombinogenic adeno-associated virus (AAV) donor vectors enables site-specif

41 tasis in AMD, we delivered recombinant adeno-associated virus (AAV) encoding Abeta42 and Abeta40 pept

42 Adeno-associated virus (AAV) entry is determined by its intera

43 Stable delivery of adeno-associated virus (AAV) expressing cKL to diabetic endoth

44 e therapy for corneal vascularization, adeno-associated virus (AAV) gene therapy, exploiting a natura

45 d via intrathecal administration of an adeno-associated virus (AAV) gene transfer vector significantl

46 Adeno-associated virus (AAV) has become a popular and successf

47 Adeno-associated virus (AAV) has become the vector of choice f

48 Adeno-associated virus (AAV) has been shown to transduce dorsa

49 Gene delivery vectors based on adeno-associated virus (AAV) have been utilized in a large num

50 CRISPR-Cas9 delivery by adeno-associated virus (AAV) holds promise for gene therapy bu

51 owever, in vivo delivery of mAgrin via adeno-associated virus (AAV) into FKRP mutant mice was unable

52 Adeno-associated virus (AAV) is a dependent virus of the famil

53 Adeno-associated virus (AAV) is a replication-deficient parvov

54 Adeno-associated virus (AAV) is frequently used to manipulate

55 y using nonintegrating viruses such as adeno-associated virus (AAV) is not optimal in this setting be

56 The life cycle of the human parvovirus adeno-associated virus (AAV) is orchestrated by four Rep prote

57 Intracellular transport of recombinant adeno-associated virus (AAV) is still incompletely understood.

58 Adeno-associated virus (AAV) is the only eukaryotic virus with

59 Delivery by adeno-associated virus (AAV) of clustered regularly interspace

60 Vectors based on adeno-associated virus (AAV) present a number of advantages an

61 protein (AAP) is a recently discovered adeno-associated virus (AAV) protein that promotes capsid asse

62 ) mRNA with donor template delivery by adeno-associated virus (AAV) serotype 6 vectors directs effici

63 Many adeno-associated virus (AAV) serotypes efficiently transduce t

64 ent of SDS-PAGE for purity analysis of adeno-associated virus (AAV) therapeutic products of different

65 To this end, we created an adeno-associated virus (AAV) to express hGRbeta in the mouse l

66 Using adeno-associated virus (AAV) to inhibit the calcineurin-depend

67 The ability to target the adeno-associated virus (AAV) to specific types of cells, by al

68 We have previously shown that the adeno-associated virus (AAV) variant, ShH10, transduces Muller

69 ously reported compassionate use of an adeno-associated virus (AAV) vector containing the human AADC

70 subretinal injection of a recombinant adeno-associated virus (AAV) vector containing the RPE65 gene

71 The adeno-associated virus (AAV) vector gene delivery system has s

72 in the dorsal striatum, we injected an adeno-associated virus (AAV) vector producing a short hairpin

73 IDUA production and function following adeno-associated virus (AAV) vector transduction of MPS1 patie

74 tered a single intravenous dose of the adeno-associated virus (AAV) vector, AAV-BR1-CAG-NEMO, deliver

75 the brains of transgenic mice using an adeno-associated virus (AAV) vector, decreased parenchymal Abe

76 rudele et al describe a novel study of adeno-associated virus (AAV) vector-mediated gene therapy that

77 with two gRNAs in a single functional adeno-associated virus (AAV) vector.

78 cted against CVB3 were delivered by an adeno-associated virus (AAV) vector.

79 Adeno-associated virus (AAV) vectors are currently the leading

80 dentified Anc80L65 from a set of other adeno-associated virus (AAV) vectors as a potent vector for th

81 Adeno-associated virus (AAV) vectors can stably express HIV-1

82 gramming of MFs into hepatocytes using adeno-associated virus (AAV) vectors expressing hepatic transc

83 trocytic CN/NFAT pathway in rats using adeno-associated virus (AAV) vectors expressing the astrocyte-

84 Herein, we review the use of adeno-associated virus (AAV) vectors for delivery of HIV bNAbs

85 We investigated adeno-associated virus (AAV) vectors for gene delivery to the

86 Immune responses in gene therapy with adeno-associated virus (AAV) vectors have been the object of a

87 Adeno-associated virus (AAV) vectors have been used successful

88 Adeno-associated virus (AAV) vectors have been widely adopted

89 Adeno-associated virus (AAV) vectors have made great progress

90 cardiac overexpression of HMGB1 using adeno-associated virus (AAV) vectors induced inflammation in t

91 Here, we created several adeno-associated virus (AAV) vectors to deliver genes that com

92 n, Y704A, near the 2-fold interface of adeno-associated virus (AAV) was defective for transcription o

93 We combined the adeno-associated virus (AAV) with the Cre-loxP site-specific r

94 grade functionality into the capsid of adeno-associated virus (AAV), a vector that has shown promise

95 e are systematically investigated with adeno-associated virus (AAV), an anterograde viral tracer.

96 present two methods for radiolabeling adeno-associated virus (AAV), one of the most commonly used vi

97 ign, RAM can be packaged into a single adeno-associated virus (AAV), providing great versatility and

98 n the life cycle of a human virus, the adeno-associated virus (AAV), that causes no known disease but

99 Second, we package the library into adeno-associated virus (AAV), thereby allowing delivery to tar

100 Adeno-associated virus (AAV)-Cre-mediated Vgf ablation in flox

101 Here, we describe a lineage-specific, adeno-associated virus (AAV)-derived endogenous viral element

102 inal neurons specifically by injecting adeno-associated virus (AAV)-expressing Cre-dependent DREADD (

103 Adeno-associated virus (AAV)-hepcidin was injected into the ey

104 We prepared adeno-associated virus (AAV)-IFN-gamma and AAV-IL-4 and studie

105 Here we report that a system of adeno-associated virus (AAV)-mediated clustered regularly inte

106 ort a genome editing approach in which adeno-associated virus (AAV)-mediated CRISPR/Cas9 delivery to

107 C cardiac manifestations in mice after adeno-associated virus (AAV)-mediated gene delivery of mutant

108 ed mice with elevated expression using adeno-associated virus (AAV)-mediated gene delivery.

109 We use adeno-associated virus (AAV)-mediated gene editing to knock in

110 While the recent success of adeno-associated virus (AAV)-mediated gene therapy in clinical

111 Adeno-associated virus (AAV)-mediated gene therapy is currentl

112 We sought to develop an efficient adeno-associated virus (AAV)-mediated RNAi gene therapy for AL

113 the therapeutic potential of naked and adeno-associated virus (AAV)-packaged AONs in vitro and in viv

114 ut, and the right CST was treated with adeno-associated virus (AAV)-Sox11 or AAV-EBFP control, along

115 strophy, dystrophin restoration during adeno-associated virus (AAV)-U7-mediated exon-skipping therapy

116 intrahippocampal administration of the adeno-associated virus (AAV)-vectored anti-phospho-tau antibod

117 These aptayzmes efficiently regulated adeno-associated virus (AAV)-vectored transgene expression in

118 CRY in SCN of Cry-deficient mice using adeno-associated virus (AAV).

119 phic mice more than a decade ago using adeno-associated virus (AAV).

120 icient delivery of donor template with adeno-associated virus (AAV).

121 cacy of telomerase activation by using adeno-associated virus (AAV)9 gene therapy vectors carrying th

122 erformed intramuscular injection of an adeno-associated virus (AAV)9 vector expressing GAA (AAV9-hGAA

123 To address this, we developed a novel adeno-associated virus (AAV-GLP-1R) that utilizes short hairpi

124 The adeno-associated viruses (AAV) are promising therapeutic gene

125 Adeno-associated viruses (AAV) are thought to spread through t

126 In the case of recombinant adeno-associated viruses (AAV), proteasome inhibitors are know

127 Here, we discovered that adeno-associated viruses (AAV1 and AAV9) exhibit anterograde t

128 hology, we investigated the effects of adeno-associated virus (AAV2/1)-mediated expression of Interle

129 Adeno-associated viruses (AAVs) are attractive gene therapy ve

130 Adeno-associated viruses (AAVs) are commonly used for in vivo

131 Recombinant adeno-associated viruses (AAVs) are promising vectors for huma

132 Adeno-associated viruses (AAVs) currently are being developed

133 ents challenges in packaging it within adeno-associated viruses (AAVs) for clinical applications.

134 The use of adeno-associated viruses (AAVs) has proven to be an effective

135 neutralizing antibodies (NAbs) against adeno-associated viruses (AAVs) pose a major, unresolved chall

136 Despite the fact that a majority of adeno-associated viruses (AAVs) utilize sialic acid (SIA) for

137 The adeno-associated viruses (AAVs), which are being developed as

138 neurons in both the MPP(+)-lesioned or adeno-associated virus alpha-synuclein rat models of Parkinson

139 s versus D2-MSNs using a Cre-inducible adeno-associated virus and Cre lines during cocaine conditione

140 specific molecular interaction between adeno-associated virus and its host cell, which can be rapidly

141 trehalose also inhibited production of cell-associated virus and partially blocked the reduction in

142 Here we designed a hybrid adeno-associated virus and phage (AAVP) vector displaying biol

143 of these two major diseases as well as their associated viruses and whitefly vector.

144 pG2 cells after HBV genome delivery by adeno-associated virus, and stable expression of NTCP in a ccH

145 including nucleic acids, polypeptides, adeno-associated viruses, and nanodots.

146 y include the emergence of recombinant adeno-associated virus as the vector of choice, capsid enginee

147 Systemic injection of adeno-associated virus-BAG3(Ile81) (n=9), but not BAG3(Met81)

148 tment of a mouse model of OPMD with an adeno-associated virus-based gene therapy combining complete k

149 transgenic mice and from WT mice after adeno-associated virus-based gene transfer of ChR2.

150 We developed an adeno-associated virus-based model exhibiting rapid tau propag

151 Leading the way has been the use of adeno-associated virus-based strategies for factor IX gene tra

152 scular administration of a recombinant adeno-associated virus-based vector (rAAV vector) expressing t

153 ong other recently identified human-like bat-associated viruses because of its high sequence homology

154 Bovine adenovirus 3, bovine adeno-associated virus, bovine influenza D virus, bovine parvo

155 We introduced adeno-associated virus carrying the gene for either the endocr

156 Using Cre-inducible adeno-associated viruses combined with D1-Cre and D2-Cre mouse

157 We injected recombinant adeno-associated virus containing the CRRY coding sequence (AA

158 neage-labeled hepatocytes by injecting adeno-associated virus containing thyroxine-binding globulin p

159 We also utilized adenovirus-associated virus-Cre to depleteLpcat3in the liver.

160 sequencing results confirmed that our adeno-associated virus-CRISPR/Cas9 strategy was very efficient

161 Adeno-associated virus-CYP46A1 infection in R6/2 mice also res

162 ng a combination of electrophysiology, adeno-associated virus-delivered fluorescent proteins, analysi

163 s and two models of type 2 diabetes by adeno-associated virus delivery of renin (ReninAAV).

164 Here, we show that adeno-associated virus-driven expression of progranulin in the

165 ession in the rostral striatum through adeno-associated virus effectively disrupted or restored dopam

166 BALB/c mice treated with adeno-associated virus encoding the BL6 BAG3 variant (Ile81; n

167 We treated mice with either adeno-associated viruses encoding a control (green fluorescent

168 le-mediated delivery of Cas9 mRNA with adeno-associated viruses encoding a sgRNA and a repair templat

169 diated endocytosis was not involved in THY-1-associated virus entry.

170 Associated virus evolution involves reassortment, recomb

171 Tissue-associated virus evolved at similar rates in cART(+) and

172 nvestigated whether exosome-associated adeno-associated virus, (exo-AAV) enabled broad retinal target

173 naling in the substantia nigra through adeno-associated virus expressing a constitutively active type

174 With neonatal administration of adeno-associated virus expressing arginase, there is near-tota

175 system by stereotaxic injection of an adeno-associated virus expressing Cre recombinase (AAV-Cre) in

176 ress-susceptible or mice injected with adeno-associated virus expressing shRNA against Cldn5 caused i

177 overproduce sclerostin as a result of adeno-associated virus expression from the liver.

178 n this study, we show that a ronivirus, gill-associated virus (GAV), encodes the 2'-O-MTase activity,

179 hat particular groups of drugs enhance adeno-associated virus gene delivery by unknown mechanisms.

180 models to determine if they increased adeno-associated virus gene delivery.

181 l for FDA-approved drug enhancement of adeno-associated virus gene therapy, which could result in saf

182 nder the umbrella term of Grapevine leafroll-associated viruses (GLRaVs).

183 ul for advancing a predictive biology of DIP-associated virus growth and infection spread.

184 Additionally, adeno-associated virus has demonstrated outstanding potential

185 In particular, coral-associated viruses have received little attention, and t

186 -Fos using photoreceptor-specific AAV (adeno-associated virus)-hRK (human rhodopsin kinase)-sh_c-fos

187 Adeno-associated virus IL-12-treated mice developed histologic

188 ucts in mouse rod photoreceptors using adeno-associated virus in Xenopus laevis rod photoreceptors us

189 to estimate the fraction of true infectious associated viruses in viral tagging experiments.

190 Epidemiological and genetic data have associated virus infections and antiviral type I interfe

191 orter genes into the safe-harbor locus adeno-associated virus integration site 1 in human embryonic s

192 dition, introduction of 3xMyc-FXR1 via adeno-associated virus into mice leads to the redistribution o

193 used a DREADD, hM3Dq, administered via adeno-associated virus into the LC under a synthetic promoter,

194 the packaging capacity of recombinant adeno-associated virus is limited while tissue-specific delive

195 It has been suggested that cell-associated virus is more efficient at transmitting HIV-1

196 viruses from previously uncharacterized tick-associated virus isolates.

197 age, which is by far the most abundant human-associated virus known, comprising up to 90% of sequence

198 Systemic delivery of dCas9/gRNA by adeno-associated virus led to reductions in pathological RNA f

199 A CSF-associated virus load of >20 copies/mL was associated wi

200 rs virus function, and we suggest that tumor-associated viruses may be more likely to contain DNA mix

201 Moreover, they demonstrated that adeno-associated virus-mediated (AAV-mediated) delivery of the

202 Furthermore, selective adeno-associated virus-mediated deletion of Esr1 in the MeA of

203 n in the adult rat substantia nigra by adeno-associated virus-mediated delivery of a short hairpin RN

204 R6/2 Huntington's disease mouse model, adeno-associated virus-mediated delivery of CYP46A1 into the s

205 6A1 expression in the striatum, via an adeno-associated virus-mediated delivery of selective shCYP46A

206 malonic encephalopathy, liver-targeted adeno-associated virus-mediated ETHE1 gene transfer dramatical

207 we explored the effects of recombinant adeno-associated virus-mediated expression of Abeta38 and Abet

208 Adeno-associated virus-mediated expression of glucocerebrosida

209 we have used anterograde tracing with adeno-associated virus-mediated expression of green fluorescen

210 g high over-expression of WT hAIPL1 by adeno-associated virus-mediated gene delivery, which was stabl

211 s and tested their efficacy in vivo by adeno-associated virus-mediated gene transfer to the brain of

212 ular localizations of each fragment by adeno-associated virus-mediated gene transfer.

213 The effects of adeno-associated virus-mediated Hrd1 knockdown and overexpress

214 Three approaches were compared: 1) adeno-associated virus-mediated in utero transfer of the ChR-2

215 Adeno-associated virus-mediated increase in AKT activation imp

216 Efficient adeno-associated virus-mediated knockdown of ZSCAN21 in the po

217 ls and in mice by peptide injection or adeno-associated virus-mediated overexpression.

218 Adeno-associated virus-mediated PSD-95 KD in the IL, but not t

219 Adeno-associated virus-mediated Snapin overexpression in the h

220 We also show that targeted adeno-associated virus-mediated suppression of claudin-5 in th

221 Adeno-associated virus-mediated targeting of RGMa to mouse DA

222 Using a novel adeno-associated virus-mediated technique to label AII amacrin

223 In contrast, transgenic or adeno-associated virus-mediated TNFAIP3 gene delivery in the l

224 Here we developed an adeno-associated virus-mediated, autochthonous genetic CRISPR

225 in an in vivo model of PD produced by adeno-associated-virus-mediated expression of alpha-syn.

226 A mitochondria-targeted adeno-associated virus (MTS-AAV) containing the mutant human N

227 stereotactic hippocampal injections of adeno-associated virus particles in APP/PS1 mice, localized pr

228 stereotactic hippocampal injections of adeno-associated virus particles in mutant hAPP Tg mouse brain

229 strategies based on SNTRVAP-displaying adeno-associated virus/phage (AAVP) particles in mice bearing

230 Adeno-associated virus-progranulin also corrected lysosomal ab

231 The adeno-associated virus-progranulin vector only transduced neur

232 intranigral injections of recombinant adeno-associated virus pseudotype 2/5 to overexpress wildtype

233 At day 28, recombinant adeno-associated virus (rAAV) (5 x 10(12) viral particles enco

234 We administered recombinant adeno-associated virus (rAAV) expressing miS1, an artificial m

235 Recombinant adeno-associated virus (rAAV) is an attractive tool for basic

236 efficient CRISPR directed recombinant Adeno-Associated Virus (rAAV) mediated gene targeting approach

237 gene therapy mediated by a recombinant adeno-associated virus (rAAV) vector expressing human G6Pase-a

238 receiving high doses of a recombinant adeno-associated virus (rAAV) vector expressing shRNAs (rAAV-s

239 he non-tumor-bearing (NT), recombinant adeno-associated virus (rAAV) vector-treated GSD-Ia mice (AAV-

240 or intrathecal injection, recombinant adeno-associated virus (rAAV) vectors can also infect sensory

241 microdystrophin genes and recombinant adeno-associated virus (rAAV) vectors is an attractive strateg

242 rapy in G6pt-/- mice using recombinant adeno-associated virus (rAAV) vectors, directed by either the

243 Here we perform recombinant adeno-associated virus (rAAV)-mediated promoterless gene targe

244 to investigate this using recombinant adeno-associated viruses (rAAV)-mediated expression of green f

245 Recombinant adeno-associated viruses (rAAVs) are commonly used vehicles fo

246 Adeno-associated virus receptor (AAVR) (also named KIAA0319L)

247 on of DISC1 in the hippocampus with an adeno-associated virus reduced the levels of BACE1, soluble Ab

248 Hepatic arginase 1 gene therapy using adeno-associated virus rescued nearly all these abnormalities

249 n transgenesis was utilized to deliver adeno-associated virus serotype 1 (AAV1) encoding human mutant

250 Specifically, we labeled adeno-associated virus serotype 10 expressing the coding seque

251 nverted terminal repeats (ITRs) in the adeno-associated virus serotype 2 (AAV2) genome significantly

252 the virus particle, self-complementary adeno-associated virus serotype 2 carrying the mutated gene (s

253 dorsal amygdala Ce-region infusions of adeno-associated virus serotype 2 containing the CRF construct

254 ol of energy homeostasis, via specific adeno-associated virus serotype 2-mediated overexpression of I

255 intravenous dose of a codon-optimized adeno-associated virus serotype 5 (AAV5) vector encoding a B-d

256 ological doses of MIS, using either an adeno-associated virus serotype 9 (AAV9) gene therapy vector o

257 gene therapy for NPC1, we constructed adeno-associated virus serotype 9 (AAV9) vectors to deliver th

258 received a single dose of intravenous adeno-associated virus serotype 9 carrying SMN complementary D

259 nt inducer of premature senescence, by adeno-associated virus serotype 9 gene transfer, resulted in a

260 /Cas9-based cardiac gene editing using adeno-associated virus serotype 9 to deliver a single short gu

261 In vivo, AAV9 (adeno-associated virus serotype 9)-mediated cardiac overexpres

262 Using intrathecal adeno-associated virus serotype 9-based delivery, the glutamat

263 lications, we found that prior in vivo Adeno-associated virus serotype 9-mediated gene delivery of GJ

264 METHODS AND Using an in vivo Adeno-associated virus serotype 9-mediated gene transfer syste

265 eart of 7-month-old SJ13 mice using an adeno-associated virus serotype-9 Cre recombinase vector (AAV.

266 Adeno-associated virus-Sesn2 was delivered to aged hearts via

267 ced by intraparenchymal delivery of an adeno-associated virus-short hairpin RNA construct was suffici

268 used mice with a mutation in Npas2 and adeno-associated virus-short hairpin RNA mediated knockdown of

269 c-specific overexpression of FGF16 via adeno-associated virus subtype 9 (AAV9) in the mutant hearts p

270 in the VTA, we delivered Cre-inducible adeno-associated virus that drives the expression of fluoresce

271 Here we describe a novel recombinant adeno-associated virus that restricts gene expression to GABAe

272 bretinal or intravitreal injections of adeno-associated virus to deliver the therapeutic gene.

273 ograde tracing to label the inputs and adeno-associated virus to trace axonal projections, we identif

274 We injected RE with adeno-associated virus to transduce cells with channelrhodopsi

275 integrations of murine leukemia virus, adeno-associated virus, Tol2 transposons or Ac/Ds transposons,

276 pinal cord after dorsal root crush and adeno-associated virus transgene expression in dorsal root gan

277 gp120 led to a significant reduction in cell-associated virus transmission.

278 pression using aerosolized delivery of adeno-associated virus type 1 (AAV1) in a large animal model o

279 Vectors based on adeno-associated virus type 2 (AAV2) are powerful tools for ge

280 ham-surgery-controlled trial assessing adeno-associated virus type 2 (AAV2)-neurturin injected into t

281 Moreover, adeno-associated virus type 2-mediated IGF2 overexpression in

282 XCL10(-/-) mice, using the neurotropic adeno-associated virus type 8 (AAV8) vector, boosted the numbe

283 of RS1 via retina-specific delivery of adeno-associated virus type 8-RS1 (AAV8-RS1) vector rescues mo

284 tolerability of escalated doses of an adeno-associated virus vector (AAV) expressing a normal ND4 co

285 reus) and guide RNA constructs into an adeno-associated virus vector and systemically delivered them

286 e transduced NAcore astrocytes with an adeno-associated virus vector expressing hM3D designer recepto

287 scid gamma (NSG) mice by the use of an adeno-associated virus vector, followed by engraftment of huma

288 Intrahippocampal injections of adeno-associated virus vectors containing the astrocyte-specif

289 ow that expression of these genes from adeno-associated virus vectors in C57BL/6 mice is able to indu

290 g in a common mouse model of AD, using adeno-associated virus vectors normalized glutamate signaling

291 patients, and gene augmentation using adeno-associated virus vectors robustly sustained the rescue o

292 hin the packaging limit of recombinant adeno-associated virus vectors that have been shown to be safe

293 Here we compare the effects of adeno-associated virus vectors with neurotrophin gene inserts,

294 blies, similar to the best recombinant adeno-associated virus vectors.

295 Our results demonstrated that cell-associated virus was less sensitive to neutralizing anti

296 In this study, adeno-associated virus was used to deliver the clustered regul

297 bited incomplete neutralization against cell-associated virus with T/F Envs, which was not observed w

298 that transcytosis of both cell-free and cell-associated viruses with diverse envelopes was significan

299 ors can package larger transgenes than adeno-associated viruses, yet lentiviral vectors remain largel

300 specific overexpression of human ZIP8 (adeno-associated virus-ZIP8 [AAV-ZIP8]) resulted in increased